Csenge Advisory Group Acquires 173 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Csenge Advisory Group lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.4% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 1,229 shares of the medical equipment provider’s stock after purchasing an additional 173 shares during the period. Csenge Advisory Group’s holdings in Intuitive Surgical were worth $490,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Baystate Wealth Management LLC lifted its position in Intuitive Surgical by 150.0% during the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares during the period. MCF Advisors LLC increased its holdings in Intuitive Surgical by 108.1% in the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 40 shares in the last quarter. Able Wealth Management LLC bought a new stake in Intuitive Surgical in the 4th quarter worth about $28,000. Atticus Wealth Management LLC grew its stake in shares of Intuitive Surgical by 85.4% during the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 41 shares during the period. Finally, MeadowBrook Investment Advisors LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $30,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG traded up $1.63 during mid-day trading on Thursday, reaching $446.37. The company’s stock had a trading volume of 903,092 shares, compared to its average volume of 1,501,547. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $448.94. The stock has a market cap of $158.33 billion, a PE ratio of 80.28, a price-to-earnings-growth ratio of 5.74 and a beta of 1.39. The company’s 50 day moving average is $414.51 and its 200 day moving average is $389.28.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same period last year, the firm earned $1.00 EPS. The company’s quarterly revenue was up 11.5% compared to the same quarter last year. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the business’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total transaction of $589,484.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total transaction of $589,484.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the transaction, the director now owns 25,319 shares of the company’s stock, valued at $9,385,753.30. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 17,956 shares of company stock valued at $6,927,011. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent research reports. The Goldman Sachs Group initiated coverage on Intuitive Surgical in a research note on Thursday, May 30th. They set a “buy” rating and a $500.00 price target for the company. Jefferies Financial Group lifted their price objective on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research report on Friday, April 19th. Stifel Nicolaus boosted their price target on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, April 8th. BTIG Research boosted their price target on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Finally, Piper Sandler upped their price objective on Intuitive Surgical from $435.00 to $490.00 and gave the stock an “overweight” rating in a report on Tuesday. Six equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $410.32.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.